What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News VHIR leads a project that searchs biomarkers to detect prematurely ovarian cancer The project will also use all the resources to determine biomarkers of response to the chemotherapy. News Vall d'Hebron leads an international project to improve the treatment of Chagas's disease Chagas's disease is a chronic one caused by a parasite, Trypasonoma cruzi. News Plenary Conference of Dr. Reventós in the Centennial Congress of the Catalan Society of Biology "Our main aim is to improve the early detection of hormo-dependent cancers". News Startup of the Barcelona Alzheimer Neuroimage Group (BANG) with the collaboration of VHIR For research in neuroimage and other biomarkers of degenerative neuronal diseases as Alzheimer. News CIBBIM participates in the Nanotechnology for Healthcare Forum Dr. Simó Schwartz, coordinator of the Molecular Biology and Biochemistry Research Centre for Nanomedicine–CIBBIM- at Vall d'Hebron Research Institute (VHIR). Dr. Schwartz' participated on July 10th in the Nanotechnology for Healthcare Forum, meeting organized by Biocat and UK Trade & Investment-Brit News Joan Comella: 'We try to return to society with science and advances the money that they invest in us' On Sunday 8th of July Dr. Joan Comella, director of Vall d'Hebron Research Institute (VHIR) was invited at the show 'Eureka' of ComRadio with occasion of the cycle of interviews with the directors of different research centers from Catalonia. During the interview he answered about the last discoveri News EUROHYP, example of project funded by FP7 The European Commission has approved the 2013 work program of the Seventh Framework Programme (FP7). This one is the last FP7 call before Horizon 2020, the innovation and research programme from 2014 to 2020, strongly linked to the strategy Europe 2020 for the growth and the occupation. For this rea News VHIR's researchers participate in the Summer course of the UIMP Two researchers at Vall d'Hebron Research Institute (VHIR) participated this week in the prestigious Summer course of the International University Menéndez y Pelayo (UIMP) of Santander. On one hand, Dr. Francisco Guarner, member of the digestive physiology and physiopathology group, took part in the News Best communication of SEPAR Congress for a work with participation of Dr. Rello A cooperative work of six Spanish hospitals with participation of Dr. Jordi Rello, head of the clinical Investigation / Innovation in the pneumonia and sepsis (CRIPS) group at Vall d'Hebron Research Institute (VHIR), has been distinguished with the best communication in the Area of Tuberculosis and News Prize of the Contest Spread Research of La Marató of TV3 for Dr. Pozo's project TV show about the Project of La Marató of TV3 "Neuroimage with SPECT in migraine for abuse of medicines", coordinated by Dr. Patricia Pozo, head of the migraine and neurological pain group at VHIR, and Dr. Joan Castell, Chief of Service of Nuclear Medicine at HUVH, has won a Prize of the Contest Sp News VHIR’s study determines multiple applications for a novel stroke biomarker Phospholipase is a marker with enormous potential: risk of stroke, risk of recurrence, response to treatment and prognosis. Until now, there has been no such complete biomarker. News VHIR participates in the first Spanish Registry of patients with McArdle's rare disease Vall d'Hebron, 12 de Octubre and Meixoeiro hospitals have collected data from 239 patients. News VHIR participates in the largest comparative study between two antidiabetic of new generation Dr. Rafael Simó, head of the diabetes and metabolism group at Vall d'Hebron Research Institute (VHIR) is the only Spanish co-author who has taken part in an international comparative study between two antidiabetic, exenatida, of new generation, and glimperidina, administered to people affected by di News Alterations in the intestinal epithelium associated with the severity of irritable bowel syndrome A team of researchers at Vall d'Hebron Research Institute (VHIR), coordinated by Dr. Maria Vicario, member of the Digestive Physiology and Physiopathology group, has identified for the first time that the small intestine presents alterations of structural proteins associated with the severity of irr News Identified for the first time four genes that predispose to suffer migraine without aura This work has identifyed four genes related to the predisposition to present the most frequent type of migraine: MEF2D, TGFBR2, PHACTR1 and ASTN2. News El VHIR participa en el Màster Oficial en Bioquímica, Biologia Molecular i Biomedicina de la UAB Ja està oberta la inscripció al Màster Oficial en Bioquímica, Biologia Molecular i Biomedicina de la U AB pel curs 2012-13. La finalitat del màster és oferir una formació de qualitat que permeti aplicar els aspectes bioquímics, biotecnològics i biomèdics al coneixement de les causes moleculars de le News Vall d'Hebron's e-learning project stands out at MIHealth Vall d'Hebron University Hospital (HUVH) participated in the presentation of the e-learning project applied to HUVH with the support of Vall d'Hebron Research Institute (VHIR) during the international congress MIHealth Forum, which took place on 24th and 25th May in Barcelona. This one was the first News Dr. Schwartz participates in the First Workshop on Nanomedicine UABCEI The First Workshop on Nanomedicine UABCEI took place on June 5th. The Workshop general objective and scope was to promote the Research and Innovation in Nanomedicine in the context of the Campus of International Excellence UABCEI.To that end, this workshop provided an opportunity to assess the poten News VHIR's study proves that DAa doesn't reduce the mortality of the septic shock In 2001, Drotrecogin alpha (activated) (DAa) was approved by the FDA for the treatment of the serious sepsis on the basis of the results of the study PROWESS. On the basis of a clinical multinational multicentral trial, double blind and controlled with placebo, DAa reduced in 6 % the mortality of th News Dr. Javier Torres awarded with the United Mitochondrial Disease Foundation Post-Doctoral Grant Dr. Javier Torres, member of the Mitochondrial Pathology and Neuromuscular Disorders group at Vall d'Hebron Research Institute (VHIR) has been awarded with the United Mitochondrial Disease Foundation Post-Doctoral Grant, that funds researchers to develop their of of postdoctoral research in the fiel Pagination First page « Previous page ‹ … Page 144 Page 145 Current page 146 Page 147 Page 148 … Next page › Last page »
